Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia

NCT00875498 is registered in ClinicalTrials.gov with Hôpital le Vinatier as lead sponsor.

NCT NCT00875498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00875498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia
Lead sponsor
Hôpital le Vinatier
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2008
Completion date
July 31, 2015
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia